 |
BD18989 |
Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3α,14β,16α)-, compd. with 5-oxo-L-proline (1:1) |
93963-52-1 |
C26H33N3O6 |
483.5567 |
VIEW DETAILS > |
 |
BD19727 |
Ethanol, 2,2′-iminobis-, N-coco alkyl derivs., compds. with nitrilotri-2,1-ethanediyl tris(dihydrogen phosphate) |
68955-57-7 |
C10H29N2O14P3 |
494.2635 |
VIEW DETAILS > |
 |
AE50539 |
Ethanol, 2,2-oxybis-, reaction products with ammonia, morpholine derivs. residues, reaction products with sulfur dioxide |
102424-23-7 |
C8H22N2O6S |
274.3351 |
VIEW DETAILS > |
 |
BD88252 |
Ethanol, [nitrilotris(methylene)]tris-, sodium salt, compd. with 2,2′,2′′-nitrilotris[ethanol] (1:2:3) |
73758-64-2 |
C9H28N2NaO12P3 |
472.2359 |
VIEW DETAILS > |
 |
BE21309 |
Erythromycin, mixt. with O-2-deoxy-2-(methylamino)-α-L-glucopyranosyl-(1→2)-O-5-deoxy-3-C-(hydroxymethyl)-α-L-lyxofuranosyl-(1→4)-N,N′-bis(aminoiminomethyl)-D-streptamine and (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
8025-30-7 |
C74H126N10O29S |
1651.9068 |
VIEW DETAILS > |
 |
AH31441 |
ethylbis[2-(oleoylamino)ethyl]ammonium ethyl sulphate |
67846-12-2 |
C44H87N3O6S |
786.2431 |
VIEW DETAILS > |
 |
BE05040 |
Eicosanoic acid, lead salt (1:?) |
94266-32-7 |
C20H40O2Pb |
519.7304 |
VIEW DETAILS > |
 |
BE15827 |
Erythromycin, 6-O-methyl-, mixt. with (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid and 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole |
209852-74-4 |
C70H102F3N7O20S2 |
1482.719 |
VIEW DETAILS > |
 |
BE04790 |
Ethanol, 2,2′-[[3-chloro-4-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]phenyl]imino]bis-, 1,1′-bis(hydrogen sulfate), sodium salt (1:?) |
124857-47-2 |
C18H22ClN3NaO14S4 |
691.0818 |
VIEW DETAILS > |
 |
BE16770 |
Ethanol, 2-[2-(decyloxy)ethoxy]-, hydrogen phosphate, compd. with 1,12-dodecanediamine (2:1) |
94108-74-4 |
C40H87N2O8P |
755.1011 |
VIEW DETAILS > |